Pablo Gonzalez

Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study

Barbara Burtness, Kevin J. Harrington, Richard Greil et al. · The Lancet · 2019 · 3.2K citations · Full text

Medicine, Oncology, Cancer Pharmacology +11

Maintenance of skin clearance with ixekizumab treatment of psoriasis: Three-year results from the UNCOVER-3 study

Craig L. Leonardi, Catherine Maari, Sandra Philipp et al. · Journal of the American Academy of Dermatology · 2018 · 67 citations

Medicine, Dermatology, Pharmacotherapy +5

The tolerability profile of clindamycin 1%/benzoyl peroxide 5% gel vs. adapalene 0.1%/benzoyl peroxide 2.5% gel for facial acne: results of a randomized, single‐blind, split‐face study

Pablo Gonzalez, Ricardo Vila, Marcela Cirigliano · Journal of Cosmetic Dermatology · 2012 · 26 citations · Full text

Pharmacy, Dermatology, Pharmacotherapy +13

Immunotherapy with an extract of Olea europaea quantified in mass units. Evaluation of the safety and efficacy after one year of treatment.

Pablo Gonzalez, Fernando Florido, Sáenz de San Pedro B et al. · PubMed · 2002 · 18 citations

Life Sciences, Immunology, Pharmacotherapy +17

The Tolerability Profile of Clindamycin 1%/Benzoyl Peroxide 5% Gel vs. Adapalene 0.1%/Benzoyl Peroxide 2.5% Gel for Facial Acne: Results of Two Randomized, Single-Blind, Split-Face Studies.

Lawrence Green, Marcela Cirigliano, Jennifer Gwazdauskas et al. · PubMed · 2012 · 13 citations · Full text

Pharmacy, Dermatology, Pharmacotherapy +11